FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to new immunoglobulins and structures based on them that are capable of specifically binding aggrecan protein.
EFFECT: pharmaceutical compositions containing immunoglobulins as an active ingredient, according to the present invention, can be used in medical practice for preventive, therapeutic or diagnostical purposes, in particular in the treatment of various joint deceases, for example osteoarthritis.
19 cl, 15 tbl, 11 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| POLYPEPTIDES RECRUITING T-CELLS, CAPABLE OF BINDING CD123 AND ALPHA/BETA TCR | 2017 |
|
RU2775063C2 |
| METHODS FOR PREDICTION, DETECTION AND REDUCTION OF NON-SPECIFIC INTERFERENCE OF PROTEINS IN METHODS OF ANALYSIS USING SINGLE VARIABLE DOMAINS OF IMMUNOGLOBULINS | 2012 |
|
RU2822520C2 |
| METHODS FOR PREDICTION, DETECTION AND REDUCTION OF NON-SPECIFIC PROTEIN INTERFERENCE IN ANALYSIS METHODS USING SINGLE VARIABLE DOMAIN OF IMMUNOGLOBULINS | 2012 |
|
RU2798971C2 |
| POLYPEPTIDES BINDING TO ADAMTS5, MMP13, AND AGGRECAN | 2018 |
|
RU2786659C2 |
| ADAMTS-BINDING IMMUNOGLOBULINS | 2018 |
|
RU2781182C2 |
| MMP13-BINDING IMMUNOGLOBULINS | 2018 |
|
RU2784069C2 |
| IMPROVED VARIABLE DOMAINS OF IMMUNOGLOBULINS | 2015 |
|
RU2746738C2 |
| IMPROVED IMMUNOGLOBULIN VARIABLE DOMAINS | 2015 |
|
RU2809788C2 |
| NGF ANTAGONISTS FOR MEDICAL USE | 2020 |
|
RU2829812C2 |
| EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
